A combination of ¿-fetoprotein, midkine, thioredoxin and a metabolite for predicting hepatocellular carcinoma Mohamed M. Omran; Khaled Farid; Mona A. Omar; Tarek M. Emran; Fathy M. El-Taweel; Ashraf A. Tabll;

Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;

Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019 Jacob Romano; Jessica Burnside; Giada Sebastiani; Alnoor Ramji; Keyur Patel; Mark Swain; Sahar Saeed;